Latham & Watkins Publishes August 2026 Drug Pricing and Medicaid Rebate Digest
Latham & Watkins released its August 2026 Drug Pricing Digest, a recurring compilation tracking developments in the Medicaid Drug Rebate Program, 340B Program, Medicare pricing policies, and state pharmaceutical regulation. The digest consolidates recent policy changes, guidance, and legal developments affecting drug pricing across federal and state programs. This is an ongoing tracker rather than a report of a single policy action. It serves as a reference resource for pharmaceutical manufacturers, health plans, and policymakers navigating drug pricing compliance and market access requirements under Medicaid and other government programs.
The digest aggregates scattered drug pricing developments into a single reference, helping Medicaid health plans and state agencies track rebate program changes and 340B policy that affect pharmacy benefit management and capitation rate setting.
Pharmacy · Managed Care
You might also like